Japan Airlines Cargo becomes the newest member of Pharma.Aero global cross-industry collaboration platform, marking a further step in integrating air cargo capabilities into the evolving landscape of pharmaceutical logistics.
As the cargo division of Japan Airlines, JAL Cargo operates a global network supporting international air freight, including temperature-controlled transport for pharmaceutical and healthcare products. With experience in handling time- and temperature-sensitive shipments within regulated environments, the company brings operational insight into quality management, compliance, and end-to-end handling processes.
The addition of JAL Cargo reflects the continued importance of airline participation in addressing the increasing complexity of life science supply chains. As new therapies, distribution models, and regulatory expectations reshape the sector, coordination between air cargo operators and other stakeholders becomes critical to ensuring continuity, visibility, and product integrity.
By becoming part of Pharma.Aero, JAL Cargo enters a structured, cross-industry dialogue involving life science manufacturers, logistics providers, airports, and technology partners. This collaborative environment enables the exchange of operational perspectives, supports the development of common approaches, and contributes to ongoing initiatives focused on improving pharmaceutical supply chain performance.
Pharma.Aero and JAL Cargo will collaborate across projects and working groups, contributing to broader efforts to enhance the reliability and transparency of global healthcare logistics.